Business Context and Reporting Period
Mustang Bio, Inc., a Delaware corporation developing gene and cell therapies, filed this Form 8-K on March 29, 2019. The report details the entry into a material definitive agreement for debt financing to support ongoing development activities.
Key Financial Metrics
This filing does not provide revenue, profit, cash flow, or margin data. The primary financial metric disclosed is the debt financing structure:
- Total Loan Facility: $20.0 million.
- Initial Funding: $15.0 million funded on the closing date.
- Contingent Funding: $5.0 million available upon achievement of predetermined milestones.
- Interest Rate: 9.00% plus the excess of the one-month LIBOR Rate over 2.50%.
- Warrant Coverage: 5% of total funded amount, resulting in 288,184 warrants with an exercise price of $3.47.
- Final Payment: $250,000 per advance ($750,000 aggregate for initial funding) due at maturity.
Material Changes
The material change reported is the execution of a venture debt agreement with Horizon Technology Finance Corporation. This agreement increases the company's indebtedness and introduces new covenants, including a liquidity covenant and limitations on dividends, further indebtedness, and corporate changes. The loan is secured by a lien on substantially all company assets, excluding Intellectual Property and Excluded Collateral.
Outlook, Risks, and Unusual Items
Repayment Terms: Interest-only payments are scheduled from May 1, 2019, through October 1, 2020, with a potential extension to April 1, 2021, contingent on meeting an Interest Only Extension Milestone. Principal amortization begins May 1, 2021, over 18 months. The first three advances mature on October 1, 2022.
Prepayment Penalties: Prepayment charges range from 4.0% to 2.0% of the outstanding principal balance depending on the timing relative to the Loan Amortization Date.
Risks and Events of Default: The agreement includes standard events of default such as payment failure, covenant breach, material adverse change, insolvency, or material defaults on other obligations exceeding $250,000. Upon default, interest rates increase by an additional 5.0% per annum, and amounts become payable on demand.
Investor Verification Checklist
- Verify the company's current cash position to assess ability to meet interest-only payments starting May 1, 2019.
- Confirm the specific milestones required to unlock the remaining $5.0 million of the loan facility.
- Review the definition of the "Interest Only Extension Milestone" to evaluate the likelihood of extending the interest-only period to 2021.
- Assess the dilution impact of the 288,184 warrants issued to Horizon Technology Finance Corporation.
- Monitor compliance with the liquidity covenant and other financial reporting covenants to avoid events of default.